PharmAust Ltd (PAA)

Sydney
Currency in AUD
Disclaimer
0.105
+0.005(+5.00%)
Closed
Day's Range
0.1050.108
52 wk Range
0.0600.115
Bid/Ask
0.10 / 0.11
Prev. Close
0.1
Open
0.105
Day's Range
0.105-0.108
52 wk Range
0.06-0.115
Volume
189,903
Average Volume (3m)
275,983
1-Year Change
54.41%
Shares Outstanding
349,341,221
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about PAA?
Vote to see community's results!
or

PharmAust Ltd Company Profile

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.

Employees
0
Market
Australia